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Abstract
Human African trypanosomiasis (HAT), also known as sleeping sickness, is a major cause
of mortality and morbidity in sub-Saharan Africa. We hypothesised that recent findings of
neurological features and parasite brain infiltration occurring at much earlier stages in HAT
than previously thought could be explained by early activation of host genetic programmes
controlling CNS disease. Accordingly, a transcriptomal analysis was performed on brain tis-
sue at 0, 7, 14, 21 and 28dpi from the HAT CD1/GVR35 mouse model. Up to 21dpi, most
parasites are restricted to the blood and lymphatic system. Thereafter the trypanosomes
enter the brain initiating the encephalitic stage. Analysis of ten different time point Compari-
son pairings, revealed a dynamic transcriptome comprising four message populations. All
7dpi Comparisons had by far more differentially expressed genes compared to all others.
Prior to invasion of the parenchyma, by 7dpi, ~2,000 genes were up-regulated, denoted
[7dpi"] in contrast to a down regulated population [7dpi#] also numbering ~2,000. How-
ever, by 14dpi both patterns had returned to around the pre-infected levels. The third,
[28dpi"] featured over three hundred transcripts which had increased modestly up to14dpi,
thereafter were significantly up-regulated and peaked at 28dpi. The fourth, a minor popula-
tion, [7dpi"-28dpi"], had similar elevated levels at 7dpi and 28dpi. KEGG and GO enrich-
ment analysis predicted a diverse phenotype by 7dpi with changes to innate and adaptive
immunity, a Type I interferon response, neurotransmission, synaptic plasticity, pleiotropic
signalling, circadian activity and vascular permeability without disruption of the blood brain
barrier. This key observation is consistent with recent rodent model neuroinvasion studies
and clinical reports of Stage 1 HAT patients exhibiting CNS symptoms. Together, these find-
ings challenge the strict Stage1/Stage2 phenotypic demarcation in HAT and show that that
significant neurological, and immune changes can be detected prior to the onset of CNS
disease.
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Author summary
Human African Trypanosomiasis, (sleeping sickness), transmitted by the endemic tsetse
fly, remains a public health and economic blight for around 70 million inhabitants of sub-
Saharan Africa. After a variable period in the haemo-lymphatic system (Stage 1), the try-
panosomes cross the blood brain barrier and enter the CNS initiating the encephalitic
(Stage 2) of the disease defined by the host’s strong immune response with attendant neu-
ropsychiatric debilitating symptoms including sleeping sickness, the hallmark symptom.
If not treated, death invariably follows. Our understanding of the contribution of the
host’s genetics to these two neuropathogenic events is poorly understood. Using a mouse
trypanosomiasis model spanning 28 days, we compared the gene expression profiles of
trypanosome infected and control mice brains over several time points. By day 7, the
activity of over 4,000 genes were altered and genetic programmes, responsible for the
development of the Stage 2 encephalitic symptoms were activated prior to any significant
breakdown of the blood brain barrier. These findings challenge this traditional Stage1/
Stage 2 phenotypic demarcation and accords with reports of Stage 1 patients presenting
with Stage 2 encephalitic symptoms and the diagnosis of asymptomatic patients reflects
the complex interaction between host and parasite genetics that impact on disease
progression.
Introduction
At least 70 million people in 36 countries throughout sub-Saharan Africa are at risk from the
neglected tropical disease human African trypanosomiasis (HAT) commonly termed sleeping
sickness. [1]. The condition results from infection of the morphologically indistinguishable
extracellular haemoflagellate protozoan parasites, the West African form Trypanosoma brucei
gambiense and the East Africa type T. brucei rhodesiense transmitted by the bite of the teste fly
(Glossina sp). The disease progresses through two distinct clinical stages [2]. During the hae-
molymphatic Stage1, the trypanosomes invade and replicate in the blood, lymphatics and
peripheral organs leading to a systemic inflammation with a variety of non-specific clinical
symptoms. After a variable period, which is more prolonged in the gambiense form, trypano-
somes invade the CNS initiating the encephalitic Stage 2 of the disease characterised clinically
by protean neurological features and pathologically by the presence in the brain of trypano-
somes, macrophages, lymphocytes, cytokines and chemokines in the CSF [3] and activation of
microglia and astrocytes [4]. This exacerbates the cytokine mediated blood brain barrier (BBB)
breakdown thereby amplifying the inflammatory response with a worsening debilitating neu-
ropsychiatric impairment and the disruption of circadian rhythm control giving rise to major
alterations of sleep structure, the hallmark CNS presentation [5]. If not diagnosed accurately,
which is essentially reliant on CSF analysis due to the lack of robust clinical staging biomark-
ers, sleeping sickness is invariably fatal. As clinical investigation studies are severely hampered
for numerous logistical reasons including ethical considerations and the very limited availabil-
ity of post-mortem material, unravelling the neuropathogenesis of HAT has been and remains
essentially dependent on a range of animal models, particularly the rodent paradigm [6, 7].
The well characterized human clinical phenotype is readily recapitulated in a range of rodent
models infected with variety of trypanosome stabilates including the human resistant species
T. b. brucei. The model employing the CD1 outbred mouse strain infected with the T. b. brucei
GVR35 stabilate, has been widely used for over 30 years in molecular pathogenesis studies and
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provides the focus of the current investigation [8, 9]. In these various studies, the consensus
has been that up to 21dpi, most parasites are essentially restricted to the haemolymphatic sys-
tem, beyond which, the infection can no longer be effectively treated with Stage-1 drugs. If not
then treated with Stage-2 drugs, the mice succumb to a combination of neurological and
immunosuppressive complications resulting in death.
As recently reviewed [10], it had been thought that parenchymal invasion was preceded by
the initial infection of the choroid plexus and the circumventricular organs via the fenestrated
endothelial layer of the blood vessels in these regions. However, a series of experiments has
challenged this strict Stage1/Stage2 demarcation. Fluorescently labelled T. b. brucei and T.b.
rhodesiense parasites were detected in the parenchyma just a few hours post-infection [11]
while in a rat model study [12] parasites and T cells were observed in the parenchyma at 9dpi.
An updated re-examination of the CD1/GVR35 model was undertaken using qPCR, Contrast
Enhanced Magnetic Resonance Imaging (CE-MRI) and histopathology. The study confirmed
the presence of trypanosome DNA in brain homogenate at 7dpi, and cellular neuropathology
and a significantly amplified CE-MRI signal at 14dpi, each criterion increasing incrementally
at later time points [13].
These rodent model findings in conjunction with reports of CNS symptoms in Stage1 rho-
desienseHAT patients suggest that BBB impairment may be more progressive and begin ear-
lier than had been previously envisaged [14]. However, it should be emphasized that when and
by what route(s) trypanosomes invade the CNS remains an ongoing and contentious issue. In
fact, the presence of parasites in the parenchyma has been challenged with the suggested alter-
native of a restricted location in the pial space of the meninges following breakdown of the
blood-CSF barrier [15] although at a later stage of infection, the trypanosomes may enter the
glia limitans leading to encephalitis and death. Despite the wealth of genetic information
accrued from targeted gene studies our understanding of the molecular mechanisms of the
two critical events in HAT neuropathogenesis, the host’s dysregulated immune response and
parenchymal invasion are poorly understood.
As reviewed [3, 16–18], the products of the Tlr9, Tlr2 andMyd88 genes have been shown to
be critical determinants in the initiation of the innate response via activation the NFκB com-
plex and subsequent expression of genes encoding the inflammatory cytokine mediators TNF-
α, IFN α/β and IFN-γ which in turn induces the expression of a panel of the chemokine genes
most notably Cxcl9, Cxcl10 Cxcr3 and Ccl5 the encoded products of which are integral to
trans-endothelial leucocyte migration. This pro-inflammatory assault is counter balanced by
the activity of several Th-2 anti-inflammatory molecules most notably IL6, IL10 and TGFβ-
1and an ensuing immune suppression phenotype with devastating neurological consequences.
Due to the inherent structural and interconnected complexities of the endothelial neurovas-
cular unit (NVU) [19], the adult quiescent BBB, though highly regulated is also fragile and sus-
ceptible to a range of insults leading to a variable degree of vascular leakage [20]. Despite an
early dye study reporting BBB damage [21], to date, there is no convincing evidence of any
permanent structural disruption of the paracellular complex of the BBB to facilitate trypano-
some migration in rodent models [22, 23]. Other proteins mechanistically involved in trypano-
some migration in rodent models are laminins 4 and 5 [24] and a small cohort of ECM
metalloproteinases [25]. A leucocyte–trypanosome coupled neuroinvasion model mediated by
the establishment of an IFNγ induced CXCL10 gradient in the astroglial endfeet of the NVU
has been proposed [26] while reduced migration was observed for both trypanosomes and T
cells into the parenchyma of TNF-α and IFN α/β null mice [18]. Treatment of cultured endo-
thelial cells with the trypanosome encoded cysteine protease brucipain can challenge the
molecular integrity of the parenchymal basement membrane resulting in transient perturba-
tion of calcium signalling [27, 28].
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The undoubted success of targeted studies has expanded our knowledge of the molecular
genetics underpinning the HAT clinical phenotype including the assembly of the African trypano-
somiasis ID5143 KEGG pathway (S1 Fig) [29] and its 38 participating genes. However, the full
complement of differentially expressed genes that drive phenotypic change await identification.
Notwithstanding well documented limitations, a microarray approach offers an unbiased experi-
mental stratagem to monitor simultaneous differential gene expression during disease progres-
sion. Somewhat surprisingly, microprofiling of T.b.brucei infected CNS material has been
restricted hitherto to two investigations by Amin and colleagues [26, 30] using the C57BL/6
inbred mouse infected with the T.b brucei stabilate AnTat 1.1E utilizing an older glass slide based
microarray technology. The first [26], was essentially a targeted study on the expression of a panel
of chemokine genes between the two pairings (6-15dpi) and (6-28dpi). The latter study was more
global in approach [30], quantifying the total number of differentially expressed genes with a GO
annotation from the three temporal pairings (6-15dpi), (6-28dpi) and (15-28dpi).
We report here the outcome of a microarray transcriptome analysis performed on whole brain
tissue collected at 0, 7, 14, 21 and 28dpi from the CD1/GVR35 HAT mouse model using the com-
mercial Illumina MouseWG6_V2_R3-11278593_A chip. Over 4000 differentially expressed genes
were subjected to a combined KEGG pathway and GO term functional enrichment analysis. In
addition, the transcriptome database was interrogated to assess the expression profile over the
28day timeline of documented and candidate trypanosomiasis genes. We surmise that by what-
ever neuroinvasion route(s) and mechanism(s) used, the presence of trypanosomes, wherever
they reside in the CNS compartment, elicits changes in the host’s transcriptome providing genetic
correlates with clinical phenotypic traits. We hypothesise here that the recent findings [11–13] of
neurological features and parasite brain infiltration occurring at much earlier stages in HAT
rodent models than previously thought might be explained by early activation of host genetic pro-
grammes controlling CNS disease. Our data shown below suggest that this is indeed the case.
Materials and methods
Ethics statement
All animal procedures were authorised under the Animals (Scientific Procedures) Act 1986,
Home Office Licence PPL60/4414 and approved by the University of Glasgow Ethical Review
Committee
Mice and infections
Innocula of 2 x 104 of T.b.brucei of the cloned stabilate GVR35 were intraperitoneally injected
into adult female CD1 mice (Charles River Laboratories). Infected CD1/GVR35 mice develop
a fluctuating parasitaemia and by 21dpi the mice cannot be treated with Stage 1 drugs. Mice
chosen for this study were all healthy littermates of similar age and weight. Three replicate
infected mice groups were euthanized and perfused at 7, 14, 21 and 28dpi in addition to a
group of four non-infected control mice equivalent to 0dpi as previously described [8]. At 7dpi
the animals were screened for the presence of trypanosomes by examination of wet blood
films. All mice were found to be parasitaemic.
Microarray analysis
Excised brains weighing around 500mg were immediately homogenized in 5ml RNABee (ams-
bio) and stored in 1ml aliquots at 80˚C for subsequent microarray and end-point RT.PCR
analyses. Total cellular RNA was prepared from infected and control brain (0dpi) replicates
according to manufacturer’s guidelines. Briefly, the RNA samples were DNase treated
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(Ambion) and column purified using a RNeasy MiniEluate Kit (Qiagen). The integrity of the
samples was assessed on an Agilent 2100 Bioanalyzer which provides an entire electrophoretic
trace of the RNA sample that evaluates the extent of degraded ribosomal species expressed as a
RIN value between 0 and 10. Multiple RNA preps were performed for each sample to ensure
(3 x 7dpi), (3 x 14dpi), (3 x 21dpi), (3 x 28dpi) and (4 x non-infected controls (0dpi)) with RIN
values� 8.5 were available for custom microarray analysis outsourced to FIOS (Fios Genomics
UK). Using the Ambion Illumina Total RNA Amplification Kit, the RNA samples were con-
verted into cDNAs and subjected to T7 in vitro synthesis to generate biotinylated cRNA and
hybridized to 50 oligomer probes printed on the MouseWG6_V2_0_R3_11278593_A Bead-
Chip and stained with streptavidin–Cy3. A single WG6 Chip contains six whole genome
microarrays each encoding 45,281 probes representing the 22,000 genes or so that comprise
the mouse genome as estimated by UniProt as from August 2020. Raw data were transformed
using a variance stabilizing transformation (VST) method prior to normalisation across all
arrays using the robust spline normalisation (RSN) method. Relative transcriptional activity
was converted to log2 expression units. From the full complement of the 45,281probeset,
23,213 were detected at least once across the arrays, with an expression hybridization signal
intensity above the fluorescence background corresponding to a log2value� 6.3, were retained
for subsequent differential gene expression analysis.
Sixteen arrays to accommodate (3 x 7dpi), (3 x 14dpi), (3 x 21dpi), (3 x 28dpi) and (4 x
0dpi) samples underwent a QC check using the QualityMetrics Bioconductor package [31].
Arrays were scored using the four parameters, maplot, boxplot, heatmap and manual inspec-
tion where 15 arrays passed QC and a non-infected control (0dpi) failed. A total of 10 single
and/or multi-factor Comparisons were analysed using linear modelling. Subsequently, empiri-
cal Bayesian analysis was applied using the Bioconductor package limma [32] and corrected
for multiple testing using the Benjamini and Hochberg method [33]. For each Comparison, the
null hypothesis was that there was no difference between the groups being compared. Compar-
isons were examined to identify expression differences at a strict statistical level (adjusted p-
value <0.001). Based on this stringent threshold, significant probes in each Comparison were
assessed using a hypergeometric test for functional enrichment (p<0.05) of KEGG pathways
and GO terms (p<0.05) based on their annotation information.
End-point RT.PCR analysis
End-point RT.PCR was performed on the same source of total cellular RNA samples that were
earmarked for microarray experimentation. Reactions were carried out in the linear amplifica-
tion range and message levels corresponding to the genes of interest were expressed relative to
the activity of the mouse housekeeping gene Cyclophilin. In brief, and as detailed elsewhere
[34], total cellular RNA was converted to cDNA using SuperScript III (Thermo Fisher Scien-
tific-UK). PCR reactions were performed on 5ng of cDNA using RedTaq Ready Mix (Sigma-
UK) against gene of interest primer sets. Thermal cycling parameters were, an initial denatur-
ation step of 94˚C/5 mins, a core cycle comprising (94˚C/1 min)/ (55˚C-65˚C/1 min)/ (72˚C/1
min) for 25–35 cycles was followed by a final extension of (72˚C/10 mins. PCR products were
separated by TAE gel electrophoresis, visualised by ethidium bromide staining and quantified
by densitometry using an UVIdocD55XD documentation system (Uvitec UK).
Results
Generation and organization of raw data
As laid out in the schematic Workflow Chart (Fig 1), a microarray analysis using the Illumina
MouseWG6_V2_0_R3_11278593_A Bead Chip was performed on GVR35 T.b brucei infected
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CD1 mouse brain RNAs collected in triplicate at 0, 7, 14, 21 and 28dpi. Biotin labelled cRNA
was hybridized to the Bead Chip and probed with streptavidin-Cy3. After a series of quality
control checks, only probes detected at least once across the arrays were retained for subse-
quent analysis. Following normalization to minimise variation gene expression measurement,
23,213 probes were designated as transcriptionally active, corresponding to over 11,000 genes.
This figure represents a brain message complexity of around 50% similar to that reported from
other mouse brain microarray studies but significantly less than the true mRNA complexity
considered to be around 80% [35]. This disparity arises in the sensitivity of microarray detec-
tion as many CNS genes are expressed at low levels and the use of whole brain homogenate as
the source of mRNA can masquerade regional brain expression differences. S1 Table lists this
collection of normalized transcripts presented in alphabetical order alongside the log2 expres-
sion unit value for each of the four time points for each replicate group and the three non-
infected control samples equivalent to 0dpi. Ten pair-wise Comparisons were performed on
this active probeset. A Comparison nomenclature that specifies the two different time point
combinations was adopted. The Infected Series compared the non-infected control equivalent
at 0dpi against the four infected time points denoted (0-7dpi)1, (0-14dpi)2, (0-21dpi)3 and (0-
28dpi)4. The Temporal Series measured activity changes between six different infected time
point combinations viz (7-14dpi)5, (7-21dpi)6, (7-28dpi)7, (14-21dpi)8, (14-28dpi)9 and (21-
28dpi)10. Expression difference for all Comparisons was set at a strict statistically significant
adjusted p value <0.001 with an attendant adaptive threshold fold change with associated sig-
nificance statistics.
The resultant transcriptome database (S2 Table) comprises a dataset for each of the ten
Comparison is set out in order of decreasing adjusted p values and corresponding fold changes
were subjected to i) differential gene expression analysis, ii) KEGG (S3 Table) and GO (S4
Table) functional enrichment analysis and iii) the database (S2 Table) was interrogated to
assess expression profiles of candidate trypanosomiasis genes (S9–S12 Tables)
Differential gene expression analysis
Quantitative transcriptome analysis. Inspection of the volcano plots (Fig 2A and 2B)
which chart differential gene expression against fold change, with the numbers of up-regulated
transcripts depicted in red and down-regulated samples in blue, reveal a dynamic quantitative
transcriptome over the 28 day timeline unveiling two key observations. First, the 7dpi Compar-
isons in both Infected (Fig 2A) and Temporal Series (Fig 2B) had the greatest activity differ-
ences relative to all other Comparisons. Secondly, there was no significant differential gene
expression in the (0-14dpi)2 and (14-21dpi)8 pairings. Transcript data for the Infection Com-
parison (0-7dpi)1 (Fig 2A) confirmed that by 7dpi the levels of 8145 mRNAs of the normalized
probeset of 23217 were altered approximating to around 4000 genes. 4360 transcripts had
increased and 3785 were down-regulated. The absence of any significant differential gene
expression activity in the (0-14dpi)2 Comparison suggests that by 7dpi or earlier, one message
population was up-regulated while the activity of the other had decreased, but by 14dpi or
before, mRNA levels of both populations had readjusted to approximately those of the non-
infected control (0dpi). This clearly demonstrates that the interval between 0 and 14dpi marks
a period of intense transcriptional activity. However, it should be recognized that the host’s
response may in part, be a consequence of a transitory systemic response to the initial trypano-
some infection. Message activity levels in the (0-21dpi)3 and (0-28dpi)4 pairings with corre-
sponding values of (37/5) and (324/30) are indicative of a post-14dpi period of increased
transcription (Fig 2A). This cyclical activity between 0 and 14dpi followed by a post-14dpi
induction was also evident in the Temporal Series profiles (Fig 2B).
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A fixed FC, usually around ±1.5–2.0 is a consensual measure of significant differential gene
expression activity in microarray analyses. S5 Table depicts transcript numbers (p<0.001) and
non-statistically filtered ± FC values ranging from ±�2 to�32 for each Comparison. The
highest FCs viz from�8 to�32 was recorded in the (0-28dpi)4, (7-28dpi)7 and (14-28dpi)9
pairings. The high FC values in (14-28dpi)9 provides supplemental evidence of post-14dpi
induced population. The highest down-FC values viz�4 (295#) and�8 (21#) was essentially
restricted to (0-7dpi)1.
When total transcript numbers were plotted against FC� 2 (Table 1), only around 30% of
the total transcript population of the 7dpi pairings (highlighted in shade), had a ± FC� 2 com-
pared to the higher values of the post-14dpi Comparisons such as 65.86% for (14-28dpi)9. This
infers that transcriptional activity between 0 and 14dpi is less expansive when measured by
FC. This besots high-throughput transcriptome studies as to the weighting to be given between
p values and corresponding FC as the true index of biological significance. This was
highlighted in a zebrafish heart tissue microarray study where the application of different FC
reported different hypoxia outcomes [36]. Accordingly, we adopted a strict statistical signifi-
cance of an adjusted p value of<0.001 and an adaptive FC threshold with its own associated
significance statistics. This implies that although around 60% have a FC< 2.0 in (0-7dpi)1
their activity may well be biologically significant.
Fig 1. Experimental workflow chart depicting generation and organization of raw data and analysis of the
transcriptome database. A microarray analysis was carried out on the brains of T. b. brucei infected mice collected at
0, 7, 14, 21 and 28dpi. Corresponding biotinylated cRNAs were hybridized to the Illumina G6_V2_0_R3_11278593
Chip encoding 45,281 oligonucleotide probes and treated with Streptavidin- generating a normalized 23,213
transcriptionally active probeset. Ten Comparisons distributed between the Infected Series [(0-7dpi)1 (0-14dpi)2 (0-
21dpi)3 (0-28dpi)4] and the Temporal Series [(7-14dpi)5 (7-21dpi)6 (7-28dpi)7 (14-21dpi)8 (14-28dpi)9 (21-28dpi)10]
generated ten transcriptome datasets which were subjected to three levels of analysis viz i) Differential gene expression
analysis, ii) KEGG/GO Functional enrichment analysis and iii) Candidate gene interrogation.
https://doi.org/10.1371/journal.pntd.0009892.g001
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Qualitative transcriptome analysis. Comparisons (0-7dpi)1, (7-14dpi)5, (0-28dpi)4 and
(14-28dpi)9 that capture key significant quantitative transcriptome changes over the 28 day
timeline (Fig 2) were selected for a limited qualitative analysis of the statistically most signifi-
cant 20 genes for each Comparison (S5 Table) and of the 25 transcripts with the highest FCs
across all Comparisons (Table 2).
As depicted in shade (S5 Table), 15 of the 20 (0-7dpi)1 down-regulated genes were up-regu-
lated in the (7-14dpi)5 Comparison. The shared (0-7dpi)1 and (7-14dpi)5 qualitative profiles,
although phenotypically disparate, could be grouped into a range of functional categories
including modulation of expression (Luc7l3, Prpf18, Pdcd4, and Gpbp1), neuronal activity
Fig 2. Volcano Plots with attendant up and down regulated transcript numbers for each Comparison. Volcano
plots that chart statistical significance (p value) versus magnitude of change (fold change) on the y and x axes,
respectively was performed on the brains of T. b. brucei infected mice at 0, 7,14, 21 and 28dpi on ten Comparisons
comprising the Infected Series (A) and the Temporal Series (B). The number of up-regulated and down-regulated
transcripts depicted in red and blue, are aligned below each the ten Comparison and corresponding volcano plot.
https://doi.org/10.1371/journal.pntd.0009892.g002
Table 1. Total transcript population plotted against the number of statistically significant mRNAs with� 2 FC
reveals variation in the level of gene activity when measured by p value differential gene expression and� 2FC.
Comparison# Total Transcript Nos � 2 FC % � 2 FC
(0-7dpi)1 8145 2370 29.06%
(7-14dpi)5 8520 2542 29.83$
(7-21dpi)6 8897 2859 32.13%
(7-28dpi)7 8959 2918 32.57%
(0-14dpi)2 0 0 0%
(14-21dpi)8 0 0 0%
(0-21dpi)3 42 35 83.33%
(0-28dpi)4 354 211 59.60%
(14-28dpi)9 208 137 65.86%
(21-28dpi)10 39 24 61.53%
https://doi.org/10.1371/journal.pntd.0009892.t001
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(Gria2, Cdkl2, Ggnbp2 and Ccdc174) pleiotropic signalling cascades (Cacnb4, Ccpg and Pak3)
and mitochondrial activity (Dnm1l andMrpl50).). This contrasts with the exclusive immune
content of (0-28dpi)4 and (14-28dpi)9 sharing eight common genes shown in shade (S5 Table)
comprises the innate response (Saa3), IFN induced Interferon Stimulated Genes (ISGs)
(Ifitm1, Ifitm3, Gm4951and Gbp3), chemokines (Cxcl9, Ccl4, Ccl5, Ccr5 and Cxcl16), comple-
ment activity (C3), the adaptive response Cd3g including antigen presentation (Cd74,H2-K2
andH2-Q8), dysfunctional immunity (Aif1) and the bacteriolytic enzymatic activity (Lyz1 and
Lyz2).
Examination of the 25 transcripts with the highest FCs across all Comparisons (Table 2)
unveiled a similar demarcation between an early neuronal dominated phenotype and the post-
14dpi immune dominated phenotype. All down-regulated genes were (0-7dpi)1 entries. This
included changes to the gene regulatory machinery (Zranb and Eif5,), mitochondrial activity
(Dnm1), signalling cascades (Camk4, Dgkb andMfap3l), neurotransmission (Gria2, Kif5c,
Slc17a6, Selt and Unc13c) and neuronal activity (Slc24a2 andMyo5a). The inclusion of the
Plp1 gene (corroborated by end-point RT.PCR) is difficult to explain as it encodes the major
protein of the CNS myelin sheath. In addition, the significance of the imprinting entries
Table 2. Twenty five genes with the highest ± FCs across all Comparisons.
Gene Symbol FC ## Adj p-value Gene Symbol FC "# Adj p-value
Small nucleolar RNAgene 1 Snhg11 -16.461 1.77E-08 CD74 antigen (invariant MHCII) Cd74 44.944 5.03E-07
Coatomer protein γ2 Copg2os2 -14.181 1.18E-09 Cysteine and glycine-rich protein 1 Csrp1 41.761 4.26E-03
Glutamate receptor α2 Gria2 -13.687 7.30E-10 Chemokine (C-X-C motif) ligand 9 Cxcl9 34.584 2.54E-06
Maternally expressed 3 Meg3 -12.021 9.83E-09 Histocompatibility 2, class II A, β1 H2-Ab1 28.804 4.72E-06
Proteolipid protein 1 Plp1 -10.766 8.10E-09 Interferon gamma induced GTPase Igtp 26.464 1.34E-06
Zinc finger, RAN-binding 2 Zranb2 -10.051 3.28E-09 Serum amyloid A 3 Saa3 24.134 6.04E-06
Solute carrier family 24r2 Slc24a2 -9.711 5.79E-09 Guanylate binding protein 2b Gbp2 23.994 3.16E-05
Eukaryotic initiation factor 5 Eif5 -8.985 4.15E-07 Chemokine 5 Ccl5 21.134 3.25E-06
Solute carrier family 17 6 Slc17a6 -8.851 3.32E-09 Chemokine 13 Cxcl13 17.834 9.86E-06
BCL2-transcription factor 1 Bclaf1 -8.521 1.49E-08 Immunity-related GTPase Irgm2 16.894 9.44E-06
Kinesin family member 5C Kif5c -8.431 8.47E-09 Coatomer protein subunit γ2 Copg2os2 16.216 8.62E-10
Selenoprotein T Selt -8.291 1.39E-08 Lysozyme 1 Lyz1 13.144 2.14E-07
Ca/calmodulin kinase IV Camk4 -8.231 8.47E-09 Histocompatibility 2, K locus 2 H2-K2 12.724 1.30E-06
Gametogenetin binding Ggnbp2 -7.871 1.97E-09 Predicted gene 8909 Gm8909 12.544 1.92E-06
Unc-13 homolog C Unc13c -7.761 1.91E-08 CD52 antigen Cd52 11.844 1.85E-06
LUC7-like 3 (S. cerevisiae) Luc7l13 -7.741 9.24E-10 Serine peptidase inhibitor, A, 3G Serpina3g 11.664 2.41E-06
Diacylglycerol kinase, beta Dgkb -6.501 5.79E-09 Lysozyme 2 Lyz2 11.654 1.64E-06
Muscleb splicing factor Mbnl1 -6.251 9.22E-09 Proteasome β type 8 peptidase 2 Psmb8 11.19 1.56E-05
Myosin VA Myo5a -5.911 1.04E-08 Interferon regulatory factor 1 Irf1 10.90 9.28E-06
Microfibrillar protein3 Mfap3l -5.621 2.34E-07 Complement component 3 Gbp3 10.54 1.94E-06
Ankyrin repeat domain 12 Ankrd12 -5.591 9.42E-07 Chemokine (C-X-C motif) ligand 10 Irgm1 9.39 1.21E-05
Dynamin 1-like Dnm1l -5.441 9.24E-10 Lymphocyte Ag 6 complex, locus A Ly6a 9.22 1.21E-05
SMG1 homolog Smg1 -5.411 1.22E-07 Complement component 3 C3 8.83 2.07E-06
Family sequence 49B Fam49b -5.291 1.02E-07 Fc receptor, IgG, low affinity IV Fcgr4 8.76 2.32E-05
Janus kinase microtubule 2 Jakmip2 -5.181 3.53E-07 Chemokine (C-X-C motif) ligand 10 Cxcl10 8.72 3.56E-05
FC ## Down-regulated genes with corresponding Comparison number#
FC "# Up-regulated genes with corresponding Comparison number#
FC ## Down-regulated genes with corresponding Comparison number#
FC "# Up-regulated genes with corresponding Comparison number#
https://doi.org/10.1371/journal.pntd.0009892.t002
PLOS NEGLECTED TROPICAL DISEASES Microprofiling the mouse CNS response to trypanosome infection
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009892 November 11, 2021 9 / 31
Copg2os2 andMeg3 is difficult to evaluate. Except for Csrp1 (neuronal development) and Cop-
g2os2 (imprinting) all other up-regulated mRNAs were found in (0-28dpi)4 and immune
exclusive. This featured the antigen presenting genes (Cd74,H2-Ab1and H2-K2). Additional
functional groupings comprised complement genes (C3 and C4a), IFNγ ISGs genes (Igtp and
Gbp2), the IFNα,β ISG (Irf1) and the chemokine genes (Cxcl9, Cxcl13 and Ccl5) in addition to
Cxcl10 which has been strongly implicated in trypanosome invasion [26]. Increased levels of
Fcgr4 mRNA encoding a Fc gamma receptor is indicative of IgG activity.
Temporal gene expression patterns. Most of the significantly active transcripts could be
grouped into one of, or variations of, four broad generic temporal gene expression patterns
denoted [7dpi"], eg Snhg11, [7dpi#], eg Sfxn3, ([28dpi"], eg Cxcl9) and [7dpi"-28dpi"], eg
Laptm5 (Fig 3). The first two, define the functionally disparate phenotype between 0 and 14dpi
with respective peak and minimum expression at 7dpi. However, it should be appreciated that
in many cases and in contrast to the highly stylized patterns represented by Snhg11 and Sfxn3,
many examples showed more gradation in the message levels between 14dpi and 28dpi partic-
ularly in the [7dpi"] population. The [28dpi"] profile represented by the chemokine gene
Cxcl9, is characterized by an initial and variable change in message levels between 0 and 7dpi
followed by a distinct post 14dpi inducible period, typically with attendant high fold changes
describes the immune dominated Comparisons (0-28dpi)4 and (14-28dpi)9 (Tables 2 and S5).
The fourth, [7dpi"-28dpi"] represent mainly immune genes, have a characteristic twin peak
pattern of similar levels as represented by the lysosomal-associated protein transmembrane 5
gene (Laptm5). As the profiles are generated from quantified message abundance at five fixed
time points, they cannot measure the extent or otherwise of the temporal length of up-regu-
lated plateaus and repressed troughs. For example, peak levels in [7dpi"] could feasibly plateau
from 3dpi to 8dpi or equally from 6dpi to 11dpi. Accordingly, these patterns should be viewed
more as useful expression trends.
Functional enrichment analysis
To gain insight of the phenotype predicted from the qualitative transcriptome database (S2
Table), a KEGG [29] and GO [37] functional enrichment analysis of all Comparisons was
undertaken as detailed in S3 and S4 Tables respectively. Due to the GO annotation selection
criteria, the number of GO terms far exceeds KEGG pathways entries (Table 3) confirming the
dominant down-regulated pattern of (0-7dpi)1 followed by the subsequent up-regulation in
(7-14dpi)5 and the post-14dpi induction in the (0-28dpi)4 and (14-28dpi)9 pairings.
Enrichment profiles for all Comparisons collated in heatmaps (S2–S5 Figs) catalogue the
statistically most significant 75 KEGG and GO entries. This confirmed two distinct phenotypes
which are boxed in each heatmap between the functionally diverse neuronal dominated phe-
notype represented in (0-7dpi)1 and (7-14dpi)5 and the post-14dpi immune dominated Com-
parisons (0-28dpi)4 and (14-28dpi)9 share an almost identical up-regulated KEGG and GO
heatmap fingerprint (S2 and S4 Figs). There was no significant KEGG or GO enrichment of
down regulated genes outwith the 7dpi Comparisons. The S2 Fig pathways, Oocyte meiosis
ID4114, Prostate cancer ID5215 and Pancreatic cancer ID5212 do not have a CNS phenotype.
This, an inherent issue of enrichment analysis termed “crosstalk” by Donato [38] arises from
common genes participating independently in different pathways and GO terms. A more
detailed KEGG analysis supplemented when appropriate with GO data, was performed to
compare the phenotypes between (0 and 14dpi) and (14 and 28dpi). KEGG pathway identifi-
ers, sourced from S3 Table were grouped into a range of functional categories reflecting phe-
notypic heterogeneity over the 28 day timeline (S6–S8 Tables) are summarized in the KEGG
bar graphs (Figs 4 and 5) plotting ten key pathways against p values for each Comparison.
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Phenotypic analysis between 0 and 14dpi. As the up-regulated profile of (0-7dpi)1mir-
rors the contents of down-regulated pathways of (7-14dpi)5 and vice versa, KEGG analysis
between 0 and 14dpi was restricted to the contents of (0-7dpi)1 (Fig 4 and S5 Table). The 12
up-regulated (0-7dpi)1 pathways (S6 Table) were classified into five broad functional catego-
ries. Selected pathways to illustrate this phenotypic diversity are listed in Fig 4 comprising
Fig 3. Representative genes for each of the four temporal generic gene expression patterns. The majority of
differentially expressed genes could be assigned to one of four temporal generic expression patterns over the 28 day
timeline designated [7dpi"] eg (Sfxn3), [7dpi#] eg Snhg11, [28dpi"] eg Cxcl9 and [7dpi"-28dpi"] eg (|Laptm5). The
two 7dpi patterns were by far the most prevalent describing the activity of over 8,000 transcripts between them while
[28dpi"] and [7dpi"-28dpi"] chart the activity of over 300 immune genes. In contrast to the representative genes,
Sfxn3 and Snhg11 many mRNAs showed more gradation post-14dpi particularly the [7dpi"] population. Some degree
of post-14dpi gradation was also evident than the highly stylized patterns of Cxcl9 and Laptm5.
https://doi.org/10.1371/journal.pntd.0009892.g003
PLOS NEGLECTED TROPICAL DISEASES Microprofiling the mouse CNS response to trypanosome infection
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009892 November 11, 2021 11 / 31
mitochondrial activity (Oxidative phosphorylation ID0190), neuronal dysfunction (Huntington
disease ID5016), metabolism (Pyrimidine metabolism ID0240), pleiotropic signalling (Notch sig-
nalling ID4330) and immune response (Systemic lupus erythematosus ID5322) in addition to GO
evidence of an early immune response supported by Interferon signalling GO:0060338 and Regu-
lation of innate response GO:0002758.
Forty of the 67 selected down-regulated (0-7dpi)1 KEGG identifiers sourced from S3 Table
were categorised into 11 broad functional groupings (S6 Table). As depicted in Fig 4 this
revealed a neuronal dominated phenotype characterised by a down-regulation in Transcrip-
tion (Ribosome biogenesis ID3008) and Protein processing (Protein processing in ER ID4141) sup-
ported by an array of down-regulated GO terms including RNA Regulation of Gene expression
GO:0010468 and Translation initiationGO:0006413. Disturbance of the neurotransmission net-
work was predicted by the inclusion of eight pathways including Serotonergic synapse ID4726,
and Dopaminergic synapse ID4728 in addition to modulation in the level of synaptic plasticity
(Long-term depression ID4730 and Long-term potentiation ID4720. Although Circadian Entrain-
ment ID4713 was down-regulated, the activity levels of the three GO terms, Entrainment of cir-
cadian clock GO:0009649, Entrainment of circadian clock by photoperiodGO:0043153 and
PhotoperiodismGO:0009648 had increased. Changes to a set of pleiotropic signal transduction
pathways [39] integral to CNS homeostasis were recorded includingMAPK signalling ID4010,
cAMP signaling ID4024 and ErbB signalling ID4012 in addition to the neural specific pathway
Neurotrophin signalling ID4722 and Calcium signalling ID4020 with critical roles in neurotrans-
mission, excitability and long-term plasticity (S6 Table). There was a decrease in B and T cell
signalling in addition to Rig1-like receptor signalling ID4622 and Nod like receptor signalling
ID4621 involved in viral and bacterial pathogen pattern recognition respectively (S6 Table). In
contrast five Type I interferon GO terms represented by Type I interferon signalling pathway
GO:0060337 and two innate terms including Regulation of innate immune responseGO:0045088
were up-regulated.
Phenotypic analysis between 14 and 28dpi. KEGG enrichment analysis of up-regulated
genes of the Temporal Comparisons (7-14dpi)5, (7-21dpi)6 and (7-28dpi)7 identified 70, 54 and
80 pathways respectively. Twenty five were chosen to represent the range of biological change
(S7 Table). The two Infected parings (0-21dpi)3 and (0-28dpi)4, yielded 12 and 50 pathways
(S8 Table). As detailed in S7 Table the balance of entries in several of the functional categories
between (7-14dpi)5 and (7-28dpi)7 were altered, most notably, those associated with neuro-
transmission, synaptic plasticity, pleiotropic signalling and the immune response, while
Table 3. Quantification of up-and down-regulated KEGG pathways and GO terms for each Comparison.
KEGG Pathways GO Terms
Infection Series Up Down Up Down
(0-7dpi)1 15 67 529 1047
(0-14dpi)2 0 0 0 0
(0-21dpi)3 10 0 286 11
(0-28dpi)4 50 1 1250 75
Temporal Series Up Down Up Down
(7-14dpi)5 70 18 1046 487
(7-21dpi)6 54 17 1050 584
(7-28dpi)7 80 21 1408 451
(14-21dpi)8 0 0 0 0
(14-28dpi)9 48 0 1020 0
(21-28dpi)10 0 0 10 0
https://doi.org/10.1371/journal.pntd.0009892.t003
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pathway numbers describing BBB activity, apoptosis and circadian activity categories were
equally represented in all three Temporal Comparisons. A summary of the content analysis of
S7 and S8 Tables have been combined in Fig 5 depicting a distinct progression from a neuronal
dominated phenotype defined in (7-14dpi)5 that increases in the immune content of the (7-
21dpi)6 and (7-28dpi)7 mixed phenotypes culminating in the appearance of an immune domi-
nated (0-28dpi)4 phenotype. Several (7-14dpi)5 neurotransmission and synaptic plasticity
pathways including Glutamatergic synapse ID4724 and Long-term potentiation ID4270 active in
(7-21dpi)6 and to lesser extent in (7-28dpi)7 marked the transition from a neuronal dominated
phenotype (7-14dpi)5 to mixed neuronal–immune phenotype in (7-28dpi)7. Evidence for this
transition in (7-21dpi)6 was the inclusion of four immune response categories including Sal-
monella infection ID5132 and Chagas disease ID5142 (Fig 5). Moreover, there was a significant
increase in the immune content between (7-21dpi)6 and (7-28dpi)7 (Fig 5) evidenced by the
four protozoan diseases, African trypanosomiasis ID5143, Chagas Disease ID5142, Leishmaniasis
Fig 4. KEGG bar graphs for ten selected up and down-regulated KEGG pathways from the (0-7dpi)1 Comparison
reveals an early neuronal dominated phenotype. Ten key up- and down-regulated pathways plotted against p values
were selected to represent biological change in the (0-7dpi)1 Comparison.
https://doi.org/10.1371/journal.pntd.0009892.g004
Fig 5. KEGG bar graph for ten up-regulated KEGG pathways selected from Comparisons (7-14dpi)5, (7-21dpi)6,
(7-28dpi)7 and (0-28dpi)4 depicting an early neuronal dominated phenotype and its transition to an immune-
dominated phenotype during disease progression. Ten key upregulated pathways plotted against p values were
selected to represent biological change for each Comparison.
https://doi.org/10.1371/journal.pntd.0009892.g005
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ID5140 and Toxoplasmosis ID5154 in addition to the innate markers TLR signalling ID4620 and
NF-k B signalling ID4064.
Compared to the (7-21dpi)6 and (7-28dpi)7 mixed phenotypes (S7 Table and Fig 5), the (0-
21dpi)3 12 listed pathways listed in the 25 (0-28dpi)4 entries, were exclusively immune (S8
Table and Fig 5). As both (0-28dpi)4 and (14-28dpi)9 share 48 of 50 pathways (S3 Table), the
25 selected (0-28dpi)4 pathways were grouped into seven functional categories (S8 Table) Five
of these, feature in Fig 5 including innate activity (Cytosolic DNA sensing ID4623, TLR signalling
ID5166 and NFkappaB ID4630), adaptive activity (Antigen processing and presentation ID4612)
immune-signalling (Chemokine signalling ID4062 and Cytokine-cytokine receptor interaction
ID4060), protozoan infection (Toxoplasmosis ID5145, Chagas Disease ID5142 and African try-
panosomiasis ID5143) and diapedesis (Leukocyte trans-endothelial migration ID4670). Further
evidence of diapedesis genetic activity was the inclusion of Cell Adhesion Molecule ID4514 (S7
Table) corroborated by three up-regulated “leucocyte” and four “T cell” migration GO terms
eg Leucocyte migration GO:0050900 and Positive regulation of T cell migration GO:2000406 in both
(0-28dpi)4 and (14-28dpi)9 (S4A Table).
Despite CE-MRI evidence of an increase in barrier permeability in GVR35/CD1 brains
[13], there was no significant change in the activity of the Tight junction ID04530 (S3 Table) or
in any of the GO “tight junctions” or “blood brain barrier” GO terms (S4 Table). However, the
up-regulated activities of Blood vessel developmentGO:0001568, Vasculature development
GO:0001944 and Blood microparticleGO:0072562 terms in (0-28dpi)4 may be indicative of a physi-
ological disturbance of vasculature homeostasis (S4A Table).
Expression profiling of candidate genes
The transcriptome database (S2 Table) was interrogated to determine the 28 day expression
patterns of the 38 African trypanosomiasis ID5143 genes and a panel of proposed Stage 2 bio-
marker genes (S9 Table) in addition to candidates associated with pathogenic change (S10
Table), the host’s immune response (S11 Table) and BBB integrity/impairment (S12 Table).
Although default expression parameters were initially set to an adjusted p value of< 0.001 and
FC around 1.5, the significance of these parameters was also assessed within the context of
individual gene function and expression pattern. The format of these S Tables depicts the Com-
parison number with the maximum fold change denoted (Max FC#), its corresponding
adjusted p value and best fit transcription expression pattern (Fig 3) for each gene.
African trypanosomiasis ID5143 and Biomarker genes. Of the 38 African trypanosomia-
sis ID5143 pathway genes (S9A Table) nine could not be detected including Kng1 and 2 encod-
ing the kallikrein-kinin hormonal cascade in addition to Il12b and the E-selectin gene Sele
while the levels Il12a, Apoa1, Fasl and Plcb2 message were subthreshold. The remainder were
significantly active describing innate immunity (Myd88 and Tlr9), cytokine activity (Ifnγ and
Il1β), diapedesis (Vcam1 and Icam1) globin synthesis (Hba-a1 and Hbb-b2), tryptophan
metabolism (Ido1) and apoptosis (Fas) all defined by the [28dpi"] or [7dpi"-28dpi"] expres-
sion patterns in contrast to Thop1 (circadian activity) and six neuroinvasion genes (eg Gnaq
and Prkca) that shared a [7dpi"] profile. The expression profiles of a panel of candidate bio-
markers [40–42] based on elevated Stage 2 CSF levels of CXCL8, CXCL10, CXCL13, ICAM1,
VCAM1, beta-2-microglobulin (B2M), MMP-9, SSP1 (Osteopontin), the human fatty acid
binding protein-3 (FABP) and the GTP metabolite, neopterin were assessed (S9B Table). The
chemokines, CAMs and B2mmRNAs peaked at 28dpi with attendant high FCs. The Gch1gene
encoding guanosine triphosphate cyclohydrolase responsible for neopterin synthesis was up-
regulated by 7dpi while Spp1 encoding osteopontin a secreted phosphoprotein was repressed
at 7dpi compromises their biomarker candidacy in this mouse model. The activities of Fabp3
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andMnp9 were subthreshold. Amin et al [30] identified 13 non-chemokine/cytokine secreted
biomarkers six of which B2m Grn, Reln, Tspo, Slpi, and Lcn2 had comparable FCs. The extra-
hepatic gene Saa3, encoding the serum amyloid acute phase protein SAA3 which is secreted
into the CSF had a classic [28dpi"] pattern with a 26.4 FC may justify biomarker investigation.
Pathogenic genes. The levels of 8145 transcripts were altered by 7dpi (Fig 2). Screening
this population identified 12 disparate functional categories (S10 Table) that may lead to path-
ogenic change. This listing comprised 11 entries involved in neurotransmission eg (Kif5c
[7dpi#]) three CAM genes eg (Cntn1 [7dpi#]), 14 apoptosis gene bank members (ApoCanD)
[43] eg (Bicr2 [7dpi#]) and eight Apoptosis ID4210 participants eg (Pik3r1 [7dpi#]), a cohort of
heat shock proteins eg (Hspa9 [7dpi#]) which may have a role in neural proteostasis and neu-
roinflammation [44] and eight members of the Dnaj/Hsp40 gene family encoding co-chaper-
ones for HSP70 proteins [45] eg (Dnajc4 [7dpi"]). Fifty genes of the multi-functional Coiled-
coil domain (Ccdc) family [46] were active eg (Ccdc124 [7dpi"]). In addition, there was an up-
regulation of five lysosomal protease storage cathepsin genes eg (CtsZ [7dpi"-28dpi"]). Four
Serpin genes eg (Serpina 3g), belong to a large family of protease inhibitors [47] had a [28dpi"]
incremental pattern. There was a spread of core histone gene activity eg (H2ac7 [7dpi]). In
addition, to their global role in the cell cycle regulation, histone core and histone modifying
genes dominate the gene profiles of the immune disease pathway SLS (Lupus) ID5322 and the
dysfunctional synaptic activity that defines Alcoholism ID5034 pathway.
The human Slc super-family with over 400 transporter genes organized into 65 functional
families [48] have crucial neurologic roles including synaptic activity and in conjunction with
the Abc gene family, regulate the efflux and influx of small molecules across the BBB. Changes
to this expansive transport network can disrupt CNS homeostasis as documented by the 71 Slc
genes associated with human brain disorders [49]. In the mouse, over 250 genes were
expressed in the brain [50]. By 7dpi around 100 were up-regulated while the activity of over 50
were decreased by 7dpi (S2 Table). The 26 selected represent the breadth of CNS function (S10
Table) including nine members were associated with neurotransmission including eg Slc6a9
[7dpi"] and Slc17a6 [7dpi#], six were enriched in the BBB [51] eg Slc2a13 [7dpi#] and Slc1a3
[7dpi#] encoding the glucose transporter GLUT13 and the glutamate transporter EATT
respectively and six Circadian Gene Data Base (CGDB) genes [52]. In contrast to the vast
majority of Slc genes which have a 7dpi expression pattern, SlcO2b1 (anion transport) Slc15a3
(proton-dependent transport of histidine) and Slc11a1 had a [7dpi"-28dpi"] profile.
A scan of the (0-7dpi)1 dataset identified around 50 circadian gene candidates, the majority,
entries in the CGDB [52]. Included in the selected 26 (S10 Table) were a subset of SCN
enriched core “clock” genes [53] was the eponymous Clock gene [7dpi#] and Per1 [7dpi"]
both of which have been reported to be altered in rodent models [54, 55]. The remainder of
candidates were classified as SCN enriched non-clock [56] including four high FC genes (S10
Table) with established roles in signalling or rhythmicity were the down regulated AMPA glu-
tamate receptor genes Gria1 and Gria3, Itpr1 (Calcium signalling) and Scg2 encodes a member
of the secretogranin family of neuroendocrine secretory proteins. An earlier study [57]
reported a reduction in GRIA2 and GRIA3 levels in SCN slice preparations consistent with
our finding on the reduced levels of the corresponding message levels in (0-7dpi)1. Other can-
didates of note included Avp [7dpi"] and Vip [7dpi#] encoding vasoactive peptides, crucial
for regulated SCN output following photic stimulation, the Pmch [7dpi#] andHcrt [7dpi"]
genes encoding the contrasting sleep-promoting melanin and wake-promoting orexin neuro-
peptides respectively and the African trypanosomiasis ID5143 Thop1 gene [7dpi"]. Given that
most SCN neurons are GABAergic, the activities of two of the receptor genes Gabrb1 [7dpi#]
and Gabrd [7dpi"] may be significant.
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Changes occur in aromatic amino acid metabolism during trypanosomiasis including a
decrease in tryptophan levels [58]. The activity of three metabolic tryptophan genes, Ccbl1
[7dpi"], Inmt [7dpi"] and Tph2 [7dpi#] was altered (S10 Table). Tryptophan levels, in part
are regulated by indoleamine 2,3-dioxygenase, encoded by the African trypanosomiasis ID5143
Ido1gene (S1 Fig) was incrementally expressed [28dpi"]. This is a rate limiting enzyme in the
kynurenine pathway, several pathway catabolites are associated with the inflammatory
response [59]. Despite the importance of the pro-inflammatory neuropeptide Substance P [60]
in addition to prostaglandins D2 and E2 and nitric oxide as depicted in the African trypanoso-
miasis ID5143 no significant changes were detectable in any of the corresponding genes.
There is no documented evidence of a hypoxic episode during trypanosome infection.
Despite subthreshold p values, four African trypanosomiasis ID5143 globin genes shared a
[7dpi"-28dpi"] pattern. The failure to detect erythroid enriched Gata1 and ErafmRNAs may
reduce the likelihood of blood contamination as a source ofHb signal. Globin genes in non-
erythroid tissue including neurons and glia are constitutively expressed or are induced follow-
ing a cellular insult eg hypoxia [61]. There was an up-regulation of the neuronal specific Ngb
[7dpi"] and the ubiquitously expressed Cygb [7dpi"] encoding neuroglobin and cytoglobin
respectively that may provide neuroprotection against hypoxic attack [62], however, the physi-
ological role of these neural globins remains equivocal [63]. Two participants of hypoxia HIF
signalling ID4066 pathway, the endothelial specific transferrin receptor gene Tfrc necessary for
iron uptake and the Pdha1 gene encoding the key enzyme pyruvate dehydrogenase were
down-regulated with attendant high FCs.
The activities of a small panel of myelin genes including the three high FC CNS myelin
structural genes Plp1,Mobp and Omg, Nsmaf, a sphingomyelin enzymatic gene, a myelin tran-
scription factor geneMyt1l andMal1 involved in myelin sheath maintenance were decreased
by 7dpi (S10 Table). The length of this transient dysregulation period may be sufficient to chal-
lenge the structural integrity of the CNS myelin sheath. Under physiological conditions, neu-
rons are reliant on oligodendroglial support in ensuring the correct propagation of action
potentials which may impact synaptic activity.
Host immunity genes
Over 300 immune genes, the majority described either by the [28dpi"] or the minor [7dpi"-
28dpi"] expression profile were expressed during infection (S2 Table). Selected genes to repre-
sent the spectrum of the host’s response categorised into nine functional groupings are detailed
in S11 Table. This revealed a panel of markers for both innate immunity (microglia (Tmem119
[7dpi"-28dpi"] and macrophagesMpeg1 [28dpi"]) and adaptive immunity (the immunopro-
teasome gene Psmb8 [7dpi"-28dpi"] and the two high FC genes MHC class II Cd74 and the
MHC I beta-2-microglobulin (β2M) (S11 Table). Genetic evidence of early diapedesis activity
was inferred by the expression patterns of Selpg [7dpi"-28dpi"] encoding the E-selectin ligand
and Icam2 [7dpi"-28dpi"] in addition to the Cam integrin genes Itgb4 and Itga7 [7dpi"] (S11
Table). Of note was the activity and diverse function of three other CAM genes sharing the
[28dpi"] pattern. Cd274, with a high FC expresses the programmed death ligand-1 (PD-L1)
leading to T cell suppression, Cd40 is a member of the Tnfr superfamily and Cd86 involved in
T lymphocyte proliferation (S11 Table). The high activity level (26.4 FC) of the extrahepatic
gene Saa3, encoding the serum amyloid acute phase protein SAA3 which is secreted into the
CSF had a classic [28dpi"] pattern may justify biomarker investigation as Stage2 biomarker as
is the Cd74 gene (44.94 FC) (S11 Table).
Raised levels of IgM and IgG are recognised in African trypanosomiasis ID5143 (S1 Fig).
Although 13 (14-28dpi)9 “immunoglobulin” GO: terms were up-regulated, no annotations
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specific to IgM or IgG activity were recorded. Indirect evidence of IgM activity was inferred
from the expression kinetics of theMzb1 gene [28dpi"] which is involved with IgM assembly
and secretion, but not IgG [64] while Igj [28dpi"] encoding a polymerizing protein that links
IgM monomers. There was an increase in the levels of the Fc gamma receptors genes (Fcγr),
particularly Fcgr4 and Fcgr3 based on FC values and to a lesser extent Fcgr2b. These multifunc-
tional Fcγr genes that share a [28dpi"] pattern may be indicative of late IgG activity (S11
Table).
Expression of these 300 genes or so, underpinning both innate and adaptive immunity are
in part orchestrated by a panel of documented cytokines and a network of chemokines as out-
lined below.
The cytokine gene expression profile. As noted previously, five GO terms were up-regu-
lated by 7dpi (S4 Table) consistent with the common [7dpi"] pattern for Ifn α/β, Ifnβ1 and the
cognate transcription factor gene Irf3 (S11 Table). An earlier study reported a role for Type I
IFNs in early resistance [65] while the Ifn α/β receptor KO mouse had a reduced number of
trypanosomes in the parenchyma compared to wild type [18]. In addition to Ifn α/β, the pro-
inflammatory Th1 response comprised Ifnγ, Tnfα, Il1α, Il1β, and Il18, all with a [28dpi"] pro-
file. The inflammasome, a pathogen sensor mediates the activation of caspases-1 and 4 that
cleave the pre-IL1 β and IL18 polypeptides to release the highly pro-inflammatory cytokines
[66]. Both caspase genes, in addition to Il1β, and Il18 shared the incremental [28dpi"] pattern.
There was no evidence of a Th17 mediated pro-inflammatory response. Th2 anti-inflamma-
tory activity was limited to Tgfb-1 [7dpi"-28dpi"] in addition to Il6 and Il10, both with a
[28dpi"] profile as had their corresponding receptor genes. Two other active interleukin genes
were Il15 [28dpi"] associated with GABA and serotonin transmission [67] and Il34 [7dpi"]
encoding a ligand for the microglia receptor CSF1R [68] had a [7dpi"-28dpi"] profile. Unlike
the afore described cytokines with modest FCs, the Ik cytokine gene with a [7dpi#] pattern
had a high FC. The encoded nuclear spliceosomal RED protein represses the expression of
(MHC) class II induced antigens by IFNγ [69]. A comparison of the cytokine gene expression
profile described here with African trypanosomiasis ID5143 and a rodent brain compilation
study [3] identified a string of common genes are highlighted in in shade (Table 4). Notable
differences were the absence Il12a and Il12b from the rodent brain profiles and the absence of
IlIa from African trypanosomiasis ID5143.
JAK-STAT activity initiates interferon cytokine ligand binding leading to the transcription
of a myriad of key IFNα/β and IFNγ families of ISGs most with a [28dpi"] or [7dpi"-28dpi"]
pattern (S11 Table), several with a high FC. Prominent IFNα/β ISGs included members of the
Interferon Regulatoryu Factor (Irf) family [70], the IFN-induced transmembrane protein
(Ifitms) grouping [71] and the IFN-induced protein with tetratricopeptide repeats (Ifit) family
[72]. The guanylate-binding protein GTPases families the small 47 kDa Immunity-Related
GTPases and 65-67Kda family play a pivotal role in the type 2 interferon response. In addition,
Gvin a member of a very high MW GTPase family of unknown function was active [73].
There was genetic evidence of Type 1 IFN suppression by the increased Stage 2 message lev-
els of suppression marker genes Cd274, Parp14 Trim21 and Usp18 [74] with a common
[28dpi"] pattern. The activity of two genes Socs3 [28dpi"] and Pias3h [7dpi#] was altered
Table 4. Comparison of cytokine gene expression profiles derived from this study, African trypanosomiasis ID5143 KEGG pathway and the Masocha compilation
[3].
This study Ifnαβ Ifnγ Tnfα Il1α Il1β Il18 Il10 Tgfβ Il15 Il34 Ik
HAT KEGG Ifnγ Tnfα Il1β Il18 Il6 Il10 Il12a Il12b
Masocha [3] Ifnαβ Ifnγ Tnfα Il1α Il1β Il6 Il10 Tgfβ
https://doi.org/10.1371/journal.pntd.0009892.t004
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which can lead to suppression of cytokine signalling by inhibition of the JAK-STAT pathway.
The forkhead transcription factor gene Foxp3 [7dpi"] has a critical role in Treg mediated sup-
pression [75].
The chemokine gene expression profile. The main drivers of the chemokine gene
response as measured by elevated FCs (S11 Table) were the Cclmembers, Ccl4, Ccl5, Ccl7 and
Ccr5 [28dpi"], the Cxcl species, Cxcl9, Cxcl10, Cxcl11, Cxcr3 Cxcl13 [28dpi"], Cxcl16 [7dpi"-
28dpi"] and Cxcl14 [7dpi"]. The Cxcl10 post-14dpi inducible pattern and to lesser extent
Cxcl9 is consistent with the predicted high CXCL10 gradient in the astrocytic endfeet of the
NVU purported to facilitate the coupled traversal of leukocytes and trypanosomes across the
BBB [26]. Using the same end-point RT.PCR stratagem, we have reported a similar expression
profile for the Ifnγ and inducible ligand genes Cxcl9, Cxcl10 and Cxcl11 and its shared receptor
gene Cxcr3 to that reported in the infected brains of a rat model of HAT [34]. In contrast to
the other CxclmRNAs, Cxcl14 had a Stage 1 [7dpi"] signature while a recent study found that
the pleiotropic CXCL14 specifically binds to CpG DNA and activates TLR9 on macrophages,
thereby inducing inflammatory cytokines [76]. This expression signature was compared
(Table 5) with a compilation profile of Ccl and Cxcl ligand genes expressed in infected rodent
brains [3]. Common genes are depicted in shade, with the exception Cxcl11 which harbours a
mutation in the C57/BL6 mouse other differences between the profiles was the presence of
Cxcl1 and Cxcl5 in addition to the grouping of Ccl genes 9, 12, 19, 21 and 28 in the Masocha
profile [3]. Although a four-fold increase in Ccl28 expression in the (6-28dpi) pairing was
reported [30], no message activity was recorded. Other active chemokine genes not featured in
the Masocha profile [3], were Cx3cl1 [7dpi"] originally termed fractalkine in man, which
unlike other chemokines has both chemoattractant and cell adhesion properties. Its cognate
receptor gene Cx3cr1 had a [28dpi"] pattern.
As detailed earlier, although most of the cytokine and chemokine genes, in addition to
many innate and adaptive immune genes had a [28dpi"] or a [7dpi"-28dpi"] profiles, several
transcripts increased incrementally between 0 and 14dpi evidence of a Stage1 immune
response. This selected panel included the innate mRNAs, Cxcl9, Cxcl13 and Ccl5 andH2-K2,
H2-DMb1and B2m as representative of adaptive immunity genes (S11 Table). This is consis-
tent with the mixed neuronal-immune phenotype predicted from the functional enrichment
analysis describing the period between 0 and 14dpi.
Brain barrier integrity/impairment genes. As laid out in S12 Table, candidate genes
associated with barrier impairment can be broadly classified whether the genetic changes are
(a) “disruptive”, involving alterations in the macromolecular architecture of the endothelia
paracellular barrier complex or (b) non-disruptive or “functional” leading to an increase in
vascular permeability caused by well documented and candidate mediators [77]. A useful
Table 5. Comparison of the chemokine ligand gene expression profiles derived from this study and Masocha compilation [3].
Masocha [3] Ccl gene ligand family Ccl2 Ccl4 Ccl5 Ccl7 Ccl9 Ccl12 Ccl19 Ccl28
This study Ccl gene ligand family (a) Ccl4 Ccl5 Ccl7 (b) (c) Ccl19 (d)
Masocha [3] Cxcl gene ligand family Cxcl1 Cxcl5 Cxcl9 Cxcl10 (e) Cxcl12 Cxcl13 Cxcl14 Cxcl16
This study Cxcl gene ligand family (a) (c) Cxcl9 Cxcl10 Cxcl11 Cxcl12 Cxcl13 Cxcl14 Cxcl16
(a). [28dpi"] Expression parameters sub-threshold
(b). [7dpi"-28dpi"] Expression parameters sub-threshold
(c). Probe not encoded on chip.
(d). mRNA not detected.
(e) Cxcl11 gene is deleted in other mouse strains
https://doi.org/10.1371/journal.pntd.0009892.t005
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resource reference for this screen was a “molecular atlas” [51] of brain enriched mRNAs
assembled from a compilation study of control and disease BBB expression databases compris-
ing 17 paracellular genes, eight members of the Abc transporter family and 39 genes belonging
to the Slc transporter super family.
(a) Disruptive changes. Excluding the endothelial gene Esam [7dpi"] encoding the endothe-
lial specific adhesion JAM protein, this screen failed to detect significant changes in the activi-
ties of any of the key paracellular barrier structural genes consistent with the subthreshold
values for the Tight Junction ID4530 and Tight junction GO:0005923. However, a set of ten ancil-
lary including Tight Junction ID4530 genes eg Ctnna1 [7dpi"], Tjap1 [7dpi"] and Exoc4
[7dpi#] were altered by 7dpi (S12 Table). A late event during the neuroinvasion process is the
enzymatic degradation of the basement membrane by the metalloproteinases, most notably
MMP2 and MMP9 [25]. However, the significance of this to the corresponding expression pat-
ternsMmp2 [7dpi"-28dpi"] andMmp9 [7dpi"] is equivocal as the expression parameters
were subthreshold. The African trypanosomiasis ID5143 (S1 Fig) schematic highlights the
importance of the laminin composition of the endothelial perivascular space during neuroin-
vasion. An immunofluorescence study observed that the ECM protein laminin 4 is permissive
for parasite migration from the parenchymal basement while laminin 5 restricts entry into the
parenchyma [24]. Despite having different expression profiles Lama4 [7dpi#]and Lama5
[7dpi"] (S12 Table), subthreshold expression parameters tempers comparisons between both
studies.
(b) Functional changes. African trypanosomiasis ID5143 (S1 Fig) incorporates a non-disrup-
tive functional neuroinvasion route based on an in vitro human endothelial layer BBB chamber
model study [27]. It has been proposed that the trypanosome encoded cysteine protease bruci-
pain binds to the membrane bound PAR2 receptor disrupting the host’s calcium signalling
network facilitating the transendothelial migration underpinned by nine denoted genes, six of
which were differentially expressed at 7dpi including the signal transduction gene Gnaq
[7dpi#] two phospholipase genes eg Plbc3 [7dpi"] and three protein kinase C genes eg Prkca
[7dpi#]. Further evidence of this critical relationship between maintenance of calcium homeo-
stasis and BBB integrity [78] was the early down-regulation of around fifty calcium signalling
genes. Of the 11 selected entries (S12 Table), Cacnb4, Camk, Ednrb and Itpr1 had high FCs in
addition to Slc24a2 and Slc8a1 encoding calcium exchangers. This was reflected in a decrease
in Calcium signalling ID4020 activity albeit at a marginal subthreshold value in addition to ten
(0-7dpi)1 GO terms eg Calcium ion transmembrane transportGO:0070588 and the up-regulation
of 18 (0-28dpi)4 terms possibly reflecting a different role for calcium post-14dpi.
Barrier homeostasis is regulated in part, by a cohort of pro- and anti-angiogenic mediators
several of which were differentially expressed albeit with modest FCs by 7dpi (S12 Table). This
included the up-regulation of three members of the VEGF/PDGF family [79], and the angio-
genic genes Angptl 4 [7dpi"], Angptl6 [7dpi"], the pro-angiogenic endothelial specific Aggf1
[7dpi#] [80] and Eng [81] [7dpi"]. In contrast to these mRNAs, an increase in the activities of,
Angpt1 and the highly endothelial enriched Angpt2 increased post-14dpi [28dpi"]. Dysfunc-
tional signalling of the Wnt/beta catenin pathway can lead to BBB breakdown [82]. The four
ligand genesWnt2,Wnt4,Wnt7a andWnt7b and its cognate receptor Fzd2 gene shared a
[7dpi"] pattern.
Perturbation in the expression of the Abc and Slc transporter gene families, particularly the
latter, as alluded to elsewhere may challenge the functionality of the BBB. In addition, an
increase in the low rate of endothelial transcytosis network during CNS disease could also
impact on vascular permeability consistent with a modest up-regulation of three well charac-
terized endothelial transcytosis genes, viz Cav1 [83] [28dpi"],Mfsd2 [84] [7dpi"] and Plvap
[85] [7dpi"]. The activity of the highly endothelial enriched Ly6amessage [28dpi"] with an
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attendant high FC may be of interest. The gene encodes a GPI-anchored protein that facilitates
the neuroinvasion of the adeno serotype AAV-PHP.B in a mouse strain specific manner,
including CD1 [86]. The Aquaporin-4 water channel encoded by the Aqp4 gene [7dpi#] was
abundantly expressed in the astroglial endfeet has a central role in CNS water regulation linked
to BBB permeability [87]. Both gene and the Vasopressin-regulated water reabsorption ID94962
pathway were down-regulated by 7dpi.
Discussion
Disease progression over the 28 day timeline of the CD1/GVR35 HAT mouse has been well
characterised in contrast to the underlying transcription profile. Based on this knowledge gulf,
the twin aims of this microprofiling study were to i): track changes to the quantitative and
qualitative transcriptomes of infected CD1 mice brains leading to the identification of message
populations and predicted phenotypic traits ii): examine the expression profiles of candidate
genes with documented or potential association with trypanosomiasis. Within the general con-
text that the infected transcriptome could be broadly divided into four message population
each with a distinct expression pattern, one critical and novel observation in addition to three
others define this study. First, the period between 0 and 14dpi was marked by the coincident
up-and down-regulation of over 8,000 transcripts approximating to around 4,000 genes. Func-
tional enrichment analysis of this population identified many of the active genetic programmes
to be associated with changes in neuronal behaviour and an early immune reaction. Second,
the levels of over 300 mRNAs associated with various aspects of the immune response were
induced post-14dpi. Third, although markers indicative of early changes in vascular perme-
ability were identified by 7dpi, there was no genetic evidence of any structural disruption to
the paracellular BBB. Fourth, candidate screening validated the expression profile of many
documented immune response genes but failed to corroborate the activity of others associated
neuropathogenesis and identified a small cohort of novel transcripts considered for further
study.
It should be emphasised that before discussing the significance of these four findings, the
interpretation of the microarray data per se should be tempered by two technical constraints.
The first, is the inherent issue of the weighting to be given between differential expression p
values and the corresponding fold change [36] as illustrated with the (0-7dpi)1 Comparison,
where only 2370 transcripts had a FC±�2 from an active message population of 8145
mRNAs. The second, concerns the detection sensitivity when using whole brain homogenates
where changes in message abundance in infected small regional loci eg BBB or SCN could be
masked by the combined expression levels in the rest of the non-infected brain. This scenario
may explain the failure to validate published data such as the endothelial basement laminin
protein genes [24] and ECM metalloproteinase genes [25].
In contrast to that reported here, there was no evidence of an equivalent period of differen-
tial gene expression activity between 0 and 14dpi in C57/BL6 brains infected with the AnTat
1.1E T.b brucei stabilate [29]. Notwithstanding these inconsistencies during Stage 1 between
the murine models, there was a similarity in gene numbers between the Amin study pairing
(6-28dpi) [29] and our equivalent Comparison (7-28dpi)4 in addition to qualitative Stage2 sim-
ilarities between the chemokine profiles [26] and in a cohort of non-cytokine/chemokine
secreted proteins [30]. These transcriptomic differences may in part arise from the variation in
the complex interplay between different combinations of host and parasite genetics. This is
consistent with the variability in trypanotolerance between a series of commonly used inbred
mouse model strains [6]. Gross differences were reported in spleen and liver pathology follow-
ing infection of two T. b. brucei genetically distinct stabilates TREU927 and STIB247 in BALB/
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c mice [88]. Variation in trypanotolerance in the cattle breeds N’Dama and Boran infected
with T. congolense [89] as well as differences in the disease profiles between T.b brucei and T.b
rhodesiense patients, the development of CNS symptoms in rhodesiense Stage1 patients [14]
and the presence of asymptomatic patients [90] all highlight the spectrum of responses elicited
by this parasite. Moreover, an intermediate stage in HAT has been proposed following
reported variation in the levels of the Stage 2 biomarkers CXCL13 and Neopterin in T b gam-
biense patients [91].
Functional enrichment analysis up to 14dpi identified genetic networks that predicted a
myriad of transient changes to metabolism, mitochondrial activity, pleiotropic signalling,
transporter activity, calcium signalling, neurotransmission including synaptic plasticity, circa-
dian activity and vascular permeability. There was also evidence of a type I interferon response,
activation of the innate system triggering both a B- and T-cell responses against trypanosome
VSG coat antigens and complement activation. These phenotypic traits can be envisaged as
the precursor for the initiation of a string of neuronal and immune changes that precede pro-
gression to Stage 2. These observations share similarities with the outcome of a T.b.brucei rat
model collaborative study reporting the detection of trypanosome DNA at 6dpi, the presence
of parasites and T cells in the parenchyma at 9dpi and significantly, early signs of circadian dis-
ruption [12]. Data from our CD1/GVR35 model [13] also detected trypanosome DNA in
brain homogenates by 7dpi and observed significant barrier impairment on CE-MRI and neu-
roinflammation at 14dpi. Moreover, intravital microscopy observations claimed the presence
of fluorescently tagged GVR35 trypanosomes within the parenchyma of infected mice as early
as five hours after infection [11]. However, this whole issue of parenchymal invasion has been
fundamentally challenged in a rat model that failed to detect trypanosomes in the parenchyma
and contended that the parasites were restricted to the pial space following breakdown of the
blood CSF barrier [15]. These combined studies purporting the early presence of parenchymal
trypanosomes may be sufficient to elicit an early expansive genetic change consistent with our
transcriptome and phenotypic observations up to 14dpi.
This period of early initiation of innate and adaptive immunity was followed by a secondary
wave of post-14dpi activity marked by an up-regulation of over 300 immune genes including a
combined grouping of immune-regulatory cytokine genes, ISG’s and chemokine genes (S11
Table) that control the innate response. The pro-and anti-inflammatory cytokine gene signa-
tures are similar with a rodent model consensus profile [3]. There was no evidence of a pro-
inflammatory Th17 response. A notable feature was an expansive increase in ISG activity com-
prising members the IFNα/β induced Irf, Ifitm and Ifit gene families and the IFNγ induced
large 65- to 67-kDa GTPases and p47GTPase gene families. Message levels of ISGs Irgm3, Ifi47
and Gbp2 were also increased during T.gondi infections [73]. Excluding the Cxcl14 gene
expression that peaked at 7dpi, the post-14dpi chemokine gene expression signature closely
resembled a rodent model compilation profile [3]. This post-14dpi period was marked by the
activity of many adaptive genes including histocompatibility H2 immunoproteasome genes
supplemented by a large grouping of “Adaptive” KEGG and GO terms. Specificity to proto-
zoan infection was confirmed by the up-regulation of six protozoan response KEGG pathways
including the eponymous African trypanosomiasis ID5143. There was evidence of shift the
immune response towards an increase in Type 1 IFN suppression inferred by the post 14dpi
activity of the suppression marker genes Cd274, Parp14 Trim21 and Usp18 [74].
By CE-MRI, we were able to quantify an increase in contrast agent leakage signal at 14dpi
[13]. However, it is unknown whether this change in permeability was “disruptive” or “func-
tional” in origin [77]. There was no evidence of expression differences in any of the major
paracellular complex genes or pathways. This is consistent with a rat study where trypano-
somes were able to cross the BBB without any loss of tight junction proteins [22] although
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dysregulated tight junction activity was claimed to account for an increase in fluorescent dye
uptake in a rat model [21]. Functional impairment could arise from the perturbed expression
between 0 and 14dpi of any of the two BBB enriched Abc and nine Slc genes [51]. During this
period there were fluctuations in genes that regulate calcium homeostasis [78] and angiogene-
sis [80–82] both processes being critical to barrier integrity. However, it remains equivocal
whether any of these proposed early transient changes could impact on functional barrier
activity to account for leakage of contrast agent from the BBB at 14dpi [13].
A recent RNASeq study [92] on transcriptomes from peripheral blood and the CSF of T.b.
rhodesiense late Stage 2 patients reported a robust innate response in the blood transcriptome
sharing genes and pathways catalogued in the (0-7dpi)1 and (7-14dpi)7 pairings. In contrast,
the late CSF transcriptome had a different expression landscape reflected in the enrichment of
anti-inflammatory and neuro-degeneration signalling pathways indicative of a more severe
and advanced neurological phenotype than the 28dpi CD1 brain homogenate. Of additional
interest were the differences between the Cxcl ligand gene profiles highlighted by the absence
Cxcl9, 10, 11, 14 and 16 and the presence of Cxcl3, 5 and 13 in the CSF.
Candidate trypanosomiasis genes with high FCs include Cd74. Generally regarded a MHC
class II chaperone, it has been shown to be multi-functional in pathological situations [93] and
was expressed at high levels in the Toxoplasma gondi infected mouse brain [94]. Others include
Csrp1 (neuronal development), Cd274 (T cell inhibition), Ly6a (neuroinvasion), three serpin
genes Serpina3g, Serpina3h and Serping1 (multifunctional protease inhibitors), Cxcl14 (7dpi
peak expression) and Saa3 as a Stage 2 biomarker. Others based on functionality are members
of the multifunctional transporter Slc gene family involved in neurotransmission and BBB
transport, several circadian genes eg Gria2, Gria3 and Itpr1 and the three BBB transcytosis
genes Cav1, Plvap andMfsd2 in addition to the Ly6a.
These changes to the neurotransmission network, the innate response, circadian activity
and vascular permeability between 0 and 14dpi merit further investigation. Using the current
experimental paradigm, with the inclusion of a series of additional time points either side of 7
and 14dpi, would provide more detailed temporal mapping of these key phenotypic changes
and define the temporal lengths of the up- and down-regulated plateaus. A similar approach
might be considered for more accurate immune mapping. This may also unravel late CNS dis-
ease genes and pathways identified in the late Stage 2 rhodesiense transcriptome study [92].
Future high throughput studies would be severely compromised using whole brain tissue.
Further investigation requires a more ambitious experimental paradigm using advanced but
established and readily accessible technologies such as Laser Capture Microdissection [95] or a
single cell–omics approach [96]. This would facilitate access to distinct functional anatomical
brain regions to generate homogenous transcriptomes and corresponding trypanosome DNA
loads. This has recently been performed on different endothelia transcriptomes [97], in addi-
tion to the SCN [53] and the choroid plexus [98]. Adopting a RNASeq experiment paradigm
to quantify homogenous cell populations coupled to the anticipated sensitivity advances in cell
imaging and CE-MRI will extend our knowledge of when and by what route(s) the trypano-
somes enter the CNS as well as reveal some of the molecular complexities of the phenotypic
traits that describe neuroinvasion, the immune response and neurological dysfunction includ-
ing disruption of the circadian network.
In conclusion, this study has reinforced the growing consensus that early neuronal and
immuno phenotypic changes precede CNS disease. This justifies the case for further investiga-
tion of the up- down- regulation wave of activity up to 14dpi and has also provided a valuable
reference resource, documenting the expression patterns of over 8000 altered transcripts.
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Supporting information
S1 Fig. African trypanosomiasis ID5143 KEGG pathway. The schematic is a combined gene
and phenotypic flow chart highlighting the IFNγ mediated initiation of the innate response
involving the TLR9-MYD88 cascade and the adaptive B cell attack on the trypanosome VSG
coat responses during Stage 1 followed by cytokine mediated breakdown of the BBB and the
role for laminins in this process. An alternative neuroinvasion route is recognised involving
disruption of calcium homoeostasis following endothelial binding of the trypanosome cysteine
protease brucipain. Parasite invasion activates a series of Stage 2 neurological pathological
changes proposing critical roles for apoptosis, NO, prostaglandins and tryptophan metabo-
lism. These key events in HAT disease progression are depicted within the framework of the
28 day timeline of the CD1/GVR35 mouse model.
(TIF)
S2 Fig. Heatmap of up-regulated KEGG pathways.
(TIF)
S3 Fig. Heatmap of down-regulated KEGG pathways.
(TIF)
S4 Fig. Heatmap up-regulated GO terms.
(TIF)
S5 Fig. Heatmap of down-regulated GO terms. Common legend to heatmaps (S2-S5).
KEGG and GO functional enrichment analyses data are depicted in the four heatmaps (S2–S5
Figs). Up-regulated KEGG pathways and GO terms are in red while blue depicts the down-reg-
ulated data. The ten Comparisons are arranged along the X axis and KEGG pathways and GO
terms lie on the Y axis. The number of displayed KEGG pathways and GO terms was restricted
to 75, presented in decreasing order of p values. Phenotypic demarcation in both KEGG and
GO profiles are boxed. Hierarchical clustering was applied to pathway and GO terms.
(TIF)
S1 Table. List of normalized transcripts. Only probes detected at least once across the 45,281
probeset spotted on the Illumina MouseWG6_V2_0_R3_11278593_A Bead Chip. were
retained for subsequent analysis. Following normalization to minimise variation gene expres-
sion measurement, 23,213 probes were designated as transcriptionally active. This collection
of normalized transcripts is presented in alphabetical order alongside the corresponding log2
expression unit value for each probe at the four time points viz 7dpi, 14dpi, 21dpi and 28dpi
for each of the three replicates denoted R1, R2 and R3 and three non-infected control samples
equivalent to 0dpi.
(XLSX)
S2 Table. Generation of transcriptome datasets. Ten pair wise Comparisons were performed
on this active probeset. Expression difference between each sample pair was set at a strict statis-
tically significant adjusted p value<0.001 with an attendant adaptive threshold fold change
with associated significance statistics. The Infected Series compared the non-infected control
equivalent to 0dpi against the four infected time points denoted (0-7dpi)1, (0-14dpi)2, (0-
21dpi)3 and (0-28dpi)4. The Temporal Series measured activity changes between six different
infected time point combinations viz (7-14dpi)5, (7-21dpi)6, (7-28dpi)7, (14-21dpi)8, (14-
28dpi)9 and (21-28dpi)10. The resultant transcriptome database (S2 Table) set out for each
pairing in order of decreasing p values and corresponding fold changes.
(XLSX)
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S3 Table. KEGG functional enrichment analysis of (A) up-regulated and (B), down-regu-
lated pathways. Up-regulated (A) and down-regulated (B) KEGG functional enrichment anal-
ysis was performed on Infected Series Comparisons (0-7dpi)1, (0-21dpi)3 and (0-28dpi)4 and
the Temporal Series Comparisons (7-14dpi)5, (7-21dpi)6, (7-28dpi)7 and (14-28dpi)9. Analysis
of pairings (0-14dpi)2, (14-21dpi)8 and (21-28dpi)10 were excluded as there was no significant
gene expression activity in theses Comparisons. KEGG pathways/ID number are set out or
each Comparison in order of decreasing order.
(XLSX)
S4 Table. GO Functional enrichment analysis of (A) up-regulated GO terms and (B),
down-regulated GO terms. Up-regulated (A) and down-regulated (B) KEGG functional
enrichment analysis was performed on Infected Series Comparisons (0-7dpi)1, (0-21dpi)3 and
(0-28dpi)4 and the Temporal Series Comparisons (7-14dpi)5, (7-21dpi)6, (7-28dpi)7 and (14-
28dpi)9. Analysis of pairings (0-14dpi)2, (14-21dpi)8 and (21-28dpi)10 were excluded as there
was no significant gene expression activity in theses Comparisons. KEGG pathways/ID number
are set out or each Comparison in order of decreasing order.
(XLSX)
S5 Table. Expression profiles of the top 20 differentially expressed genes in selected Com-
parisons (0-7dpi)1, (7-14dpi)5, (0-28dpi)4 and (14-28dpi)9.
(DOCX)
S6 Table. KEGG functional enrichment analysis of up-and down-regulated genes in (0-
7dpi)1 charting phenotypic change by grouping pathways into broad functional categories.
(DOCX)
S7 Table. KEGG functional enrichment analysis of up-regulated genes in Temporal Com-
parisons (7-14dpi)5, (7-21dpi)6 and (7-28dpi)7 charting phenotypic change by grouping
pathways into broad functional categories.
(DOCX)
S8 Table. KEGG functional enrichment analysis of up-regulated genes of Comparisons (0-
21dpi)3 and (0-28dpi)4 identifying immune phenotypic traits by grouping pathways into a
range of immune functional categories.
(DOCX)
S9 Table. a) African trypanosomiasis ID5143 and b) Stage 2 Biomarker gene expression pro-
files. The expression profiles of the 38 genes that define the African trypanosomiasis ID5143
KEGG pathway (a) and a panel of published HAT biomarker genes (b). Each gene was
matched against its Comparison # with the maximum fold change (Max FC#), adj p value and
expression pattern (Fig 3.).
(DOCX)
S10 Table. Candidate genes associated with pathogenesis. Pathogenic candidate genes, were
selected based on a high FC, inferred biological significance or both, were grouped into 13
functional categories. Each gene was matched against its Comparison # with the maximum fold
change (Max FC#), adj p value and expression pattern (Fig 3.).
(DOCX)
S11 Table. Host’s immune gene response. Immune genes were selected based on a high FC,
inferred biological significance or both, were grouped into nine immune functional categories.
Each gene was matched against its Comparison # with the maximum fold change (Max FC#),
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adj p value and expression pattern (Fig 3.).
(DOCX)
S12 Table. Candidate genes associated with BBB integrity/impairment. Candidate genes
were designated a) as “disruptive” involving structural changes to the paracellular barrier com-
plex or b) “functional” where a change in the activity of a range of non-cytokine mediators.
Each gene was matched against its Comparison # with the maximum fold change (Max FC#),
adj p value and expression pattern (Fig 3.).
(DOCX)
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